Market closed
Omega Therapeutics/OMGA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Omega Therapeutics
Omega Therapeutics Inc is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines, known as Omega Epigenomic Controllers. Using epigenomic controllers, Omega is seeking to transform the practice of human medicine through selective and direct control of the human genome to treat and cure disease. It operates in the U.S.
Ticker
OMGA
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
94
Website
OMGA Metrics
BasicAdvanced
$55M
Market cap
-
P/E ratio
-$1.43
EPS
1.86
Beta
-
Dividend rate
Price and volume
Market cap
$55M
Beta
1.86
52-week high
$6.30
52-week low
$0.99
Average daily volume
165K
Financial strength
Current ratio
2.195
Quick ratio
1.825
Long term debt to equity
423.125
Total debt to equity
483.394
Interest coverage (TTM)
-44.77%
Management effectiveness
Return on assets (TTM)
-25.37%
Return on equity (TTM)
-129.15%
Valuation
Price to revenue (TTM)
8.633
Price to book
2.08
Price to tangible book (TTM)
2.08
Price to free cash flow (TTM)
-0.809
Growth
Revenue change (TTM)
142.47%
Earnings per share change (TTM)
-35.41%
3-year earnings per share growth (CAGR)
-49.43%
What the Analysts think about OMGA
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Omega Therapeutics stock.
OMGA Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
OMGA Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
OMGA News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Omega Therapeutics stock?
Omega Therapeutics (OMGA) has a market cap of $55M as of October 12, 2024.
What is the P/E ratio for Omega Therapeutics stock?
The price to earnings (P/E) ratio for Omega Therapeutics (OMGA) stock is 0 as of October 12, 2024.
Does Omega Therapeutics stock pay dividends?
No, Omega Therapeutics (OMGA) stock does not pay dividends to its shareholders as of October 12, 2024.
When is the next Omega Therapeutics dividend payment date?
Omega Therapeutics (OMGA) stock does not pay dividends to its shareholders.
What is the beta indicator for Omega Therapeutics?
Omega Therapeutics (OMGA) has a beta rating of 1.86. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.